| Meet the University of Wisconsin-Madison’s David Beebe Professor of Pathology and Laboratory Medicine Professor of Biomedical Engineering |
 |
Research area The Microtechnology, Medicine and Biology Lab is focused on the novel and simple use of microscale physics and phenomena to create tools and methods to further biological and medical goals, ranging from basic science to research tools to diagnostics. The lab is especially interested and engaged in applying the lab’s technologies to cancer, inflammation, infectious disease and multi-kingdom interactions. A common theme is a desire to recreate in vivo complexity in vitro to understand the complex interactions that regulate normal and pathological biology. The MMB lab is multidisciplinary and collaborative, working across disciplines and disease boundaries to create solutions that can be translated into widespread use.
What excites you about your work?
“My research into microfluidic technologies and microenvironments has led to the development of multiple research tools, as well as streamlined point-of-care and lab-based diagnostics. I’m particularly excited about our recent work on microphysiological systems (MPS) technologies that provide increased biological relevance and allow the testing of drugs in a small-scale environment, as well as the use of MPS to create patient-specific models with the goal of improving clinical treatment decisions. Our lab research currently includes cancer biology, multi-kingdom interactions, infectious disease and continued small-scale physics and technology development.”
What do you hope to achieve?
“My research group collaborates with life sciences companies including Gilson, and I’ve founded or served on the board of Ratio, Tasso, Lynx Biosciences, Onexio Biosystems, Salus Discovery and Flambeau Diagnostics. I enjoy seeing my basic research get translated into products that make disease diagnosis and treatment easier and more cost-effective for people.”
David’s work will help advance research and diagnostics in a wide range of conditions from cancer to infectious disease.
– Jeanine Burmania, WARF, Senior Director, IP and Licensing
Want to learn more?
Jeanine Burmania, [email protected], 608.960.9846